David Vroman is an Ophthalmology physician. OpenAlex indexes 68 publications with 1,777 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
137 Gateway Dr
Ladson, SC 294563552
Telephone
843-797-3676Provider last certified this registry record 3 May 2023.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Research LLCProgram year20254 payments$11,740openpaymentsdata.cms.gov ↗
- Glaukos CorporationProgram year20259 payments$11,623openpaymentsdata.cms.gov ↗
- BIOTISSUE HOLDINGS INC.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
68.8%Corticosteroid36.4%Prednisolone Acetate98%Dexamethasone Sodium Phosphate2%Part D<11 patientsCorticosteroids, plain15.1%Loteprednol Etabonate94%Lotemax Sm6%Part D<11 patients+ 8 more classes in this area
Anti-infectives
23%Fluoroquinolone Antibacterial14.4%Moxifloxacin100%Part D≥146 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.6%Valacyclovir100%Part D≥29 patients+ 1 more class in this area
Cancer & immunology
4.9%Calcineurin inhibitor4.9%Restasis60%Cyclosporine40%Part D≥31 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Surgical techniques and adjuvants for the management of primary and recurrent pterygia
Journal of Cataract & Refractive Surgery
2017 - Reshaping procedures for the surgical management of corneal ectasia
Journal of Cataract & Refractive Surgery
2015 - Current knowledge about and recommendations for ocular methicillin-resistant Staphylococcus aureus
Journal of Cataract & Refractive Surgery
2014 - Influence of Race and Age on Aqueous Humor Levels of Transforming Growth Factor-Beta 2 in Glaucomatous and Nonglaucomatous Eyes
Journal of Ocular Pharmacology and Therapeutics
2010
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”